PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb2
|
ENSMUSG00000075588.7 | Hoxb2 |
Dlx2
|
ENSMUSG00000023391.9 | Dlx2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb2 | mm39_v1_chr11_+_96242422_96242461 | 0.43 | 1.8e-04 | Click! |
Dlx2 | mm39_v1_chr2_-_71377088_71377103 | -0.33 | 5.2e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_62576140 | 9.37 |
ENSMUST00000034052.14
ENSMUST00000034054.9 |
Anxa10
|
annexin A10 |
chr16_+_22737128 | 7.98 |
ENSMUST00000170805.9
|
Fetub
|
fetuin beta |
chr16_+_22737050 | 7.81 |
ENSMUST00000231768.2
|
Fetub
|
fetuin beta |
chr16_+_22737227 | 7.58 |
ENSMUST00000231880.2
|
Fetub
|
fetuin beta |
chr19_+_34078333 | 7.09 |
ENSMUST00000025685.8
|
Lipm
|
lipase, family member M |
chr9_+_43222104 | 6.95 |
ENSMUST00000034511.7
|
Trim29
|
tripartite motif-containing 29 |
chr1_-_140111138 | 5.18 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr1_-_140111018 | 5.11 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr3_+_93301003 | 4.87 |
ENSMUST00000045912.3
|
Rptn
|
repetin |
chr15_-_101602734 | 4.84 |
ENSMUST00000023788.8
|
Krt6a
|
keratin 6A |
chr5_-_134776101 | 4.54 |
ENSMUST00000015138.13
|
Eln
|
elastin |
chr17_+_35844091 | 4.19 |
ENSMUST00000025273.9
|
Psors1c2
|
psoriasis susceptibility 1 candidate 2 (human) |
chr7_+_43430459 | 4.17 |
ENSMUST00000014058.11
|
Klk10
|
kallikrein related-peptidase 10 |
chr16_+_42727926 | 3.79 |
ENSMUST00000151244.8
ENSMUST00000114694.9 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chrM_+_10167 | 3.63 |
ENSMUST00000082414.1
|
mt-Nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr15_-_101801351 | 3.62 |
ENSMUST00000100179.2
|
Krt76
|
keratin 76 |
chr10_+_53213763 | 3.45 |
ENSMUST00000219491.2
ENSMUST00000163319.9 ENSMUST00000220197.2 ENSMUST00000046221.8 ENSMUST00000218468.2 ENSMUST00000219921.2 |
Pln
|
phospholamban |
chr5_-_86521273 | 3.41 |
ENSMUST00000031175.12
|
Tmprss11d
|
transmembrane protease, serine 11d |
chr16_+_44914397 | 3.29 |
ENSMUST00000061050.6
|
Ccdc80
|
coiled-coil domain containing 80 |
chr16_-_56688024 | 3.28 |
ENSMUST00000232373.2
|
Tmem45a
|
transmembrane protein 45a |
chr18_-_43610829 | 3.14 |
ENSMUST00000057110.11
|
Eif3j2
|
eukaryotic translation initiation factor 3, subunit J2 |
chr4_-_14621805 | 3.01 |
ENSMUST00000042221.14
|
Slc26a7
|
solute carrier family 26, member 7 |
chr18_-_43925932 | 2.92 |
ENSMUST00000237926.2
ENSMUST00000096570.4 |
Gm94
|
predicted gene 94 |
chr18_+_44237474 | 2.90 |
ENSMUST00000081271.7
|
Spink12
|
serine peptidase inhibitor, Kazal type 12 |
chr10_-_85847697 | 2.88 |
ENSMUST00000105304.2
ENSMUST00000061699.12 |
Bpifc
|
BPI fold containing family C |
chr13_-_53627110 | 2.80 |
ENSMUST00000021922.10
|
Msx2
|
msh homeobox 2 |
chr4_-_14621497 | 2.73 |
ENSMUST00000149633.2
|
Slc26a7
|
solute carrier family 26, member 7 |
chr10_+_127734384 | 2.71 |
ENSMUST00000047134.8
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr7_-_28246530 | 2.69 |
ENSMUST00000239002.2
ENSMUST00000057974.4 |
Nccrp1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
chr1_+_172383499 | 2.65 |
ENSMUST00000061835.10
|
Vsig8
|
V-set and immunoglobulin domain containing 8 |
chr3_+_59989282 | 2.64 |
ENSMUST00000029326.6
|
Sucnr1
|
succinate receptor 1 |
chr10_-_107321938 | 2.62 |
ENSMUST00000000445.2
|
Myf5
|
myogenic factor 5 |
chr4_-_14621669 | 2.51 |
ENSMUST00000143105.2
|
Slc26a7
|
solute carrier family 26, member 7 |
chrM_+_9870 | 2.49 |
ENSMUST00000084013.1
|
mt-Nd4l
|
mitochondrially encoded NADH dehydrogenase 4L |
chr19_-_42117420 | 2.45 |
ENSMUST00000161873.2
ENSMUST00000018965.4 |
Avpi1
|
arginine vasopressin-induced 1 |
chr9_-_71070506 | 2.39 |
ENSMUST00000074465.9
|
Aqp9
|
aquaporin 9 |
chr14_+_33662976 | 2.34 |
ENSMUST00000100720.2
|
Gdf2
|
growth differentiation factor 2 |
chr12_-_25147139 | 2.33 |
ENSMUST00000221761.2
|
Id2
|
inhibitor of DNA binding 2 |
chr15_+_31224616 | 2.32 |
ENSMUST00000186547.7
|
Dap
|
death-associated protein |
chr18_+_4920513 | 2.29 |
ENSMUST00000126977.8
|
Svil
|
supervillin |
chr11_-_121410152 | 2.19 |
ENSMUST00000092298.6
|
Zfp750
|
zinc finger protein 750 |
chr15_+_55171138 | 2.13 |
ENSMUST00000023053.12
ENSMUST00000110217.10 |
Col14a1
|
collagen, type XIV, alpha 1 |
chr11_+_115225557 | 2.10 |
ENSMUST00000106543.8
ENSMUST00000019006.5 |
Otop3
|
otopetrin 3 |
chr13_+_75855695 | 2.05 |
ENSMUST00000222194.2
ENSMUST00000223535.2 ENSMUST00000222853.2 |
Ell2
|
elongation factor for RNA polymerase II 2 |
chr5_-_86893645 | 2.02 |
ENSMUST00000161306.2
|
Tmprss11e
|
transmembrane protease, serine 11e |
chr14_-_56181993 | 1.99 |
ENSMUST00000022834.7
ENSMUST00000226280.2 |
Cma1
|
chymase 1, mast cell |
chr8_-_62355690 | 1.97 |
ENSMUST00000121785.9
ENSMUST00000034057.14 |
Palld
|
palladin, cytoskeletal associated protein |
chr2_+_83554741 | 1.96 |
ENSMUST00000028499.11
|
Itgav
|
integrin alpha V |
chr19_-_7943365 | 1.95 |
ENSMUST00000182102.8
ENSMUST00000075619.5 |
Slc22a27
|
solute carrier family 22, member 27 |
chr1_+_107350411 | 1.86 |
ENSMUST00000086690.6
|
Serpinb7
|
serine (or cysteine) peptidase inhibitor, clade B, member 7 |
chr15_-_101482320 | 1.80 |
ENSMUST00000042957.6
|
Krt75
|
keratin 75 |
chr18_+_44237577 | 1.80 |
ENSMUST00000239465.2
|
Spink12
|
serine peptidase inhibitor, Kazal type 12 |
chr1_-_106980033 | 1.80 |
ENSMUST00000112717.3
|
Serpinb3a
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A |
chr6_+_15196950 | 1.78 |
ENSMUST00000140557.8
ENSMUST00000131414.8 ENSMUST00000115469.8 |
Foxp2
|
forkhead box P2 |
chrX_+_132751729 | 1.74 |
ENSMUST00000033602.9
|
Tnmd
|
tenomodulin |
chr3_-_49711765 | 1.72 |
ENSMUST00000035931.13
|
Pcdh18
|
protocadherin 18 |
chr11_+_67689094 | 1.71 |
ENSMUST00000168612.8
|
Dhrs7c
|
dehydrogenase/reductase (SDR family) member 7C |
chrM_+_11735 | 1.67 |
ENSMUST00000082418.1
|
mt-Nd5
|
mitochondrially encoded NADH dehydrogenase 5 |
chr2_+_83554770 | 1.63 |
ENSMUST00000141725.3
|
Itgav
|
integrin alpha V |
chr3_-_92031247 | 1.62 |
ENSMUST00000070284.4
|
Prr9
|
proline rich 9 |
chr2_+_27055245 | 1.61 |
ENSMUST00000000910.7
|
Dbh
|
dopamine beta hydroxylase |
chr14_+_51333816 | 1.60 |
ENSMUST00000169895.3
|
Rnase4
|
ribonuclease, RNase A family 4 |
chr5_-_103777145 | 1.60 |
ENSMUST00000031263.2
|
Slc10a6
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 6 |
chr3_-_49711706 | 1.59 |
ENSMUST00000191794.2
|
Pcdh18
|
protocadherin 18 |
chr18_+_84106796 | 1.57 |
ENSMUST00000235383.2
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chr10_-_43934774 | 1.51 |
ENSMUST00000239010.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr17_-_35100980 | 1.50 |
ENSMUST00000152417.8
ENSMUST00000146299.8 |
C2
Gm20547
|
complement component 2 (within H-2S) predicted gene 20547 |
chr2_+_103242027 | 1.49 |
ENSMUST00000239273.2
ENSMUST00000164172.8 |
Elf5
|
E74-like factor 5 |
chr3_+_82915031 | 1.48 |
ENSMUST00000048486.13
ENSMUST00000194175.2 |
Fgg
|
fibrinogen gamma chain |
chr13_-_114595122 | 1.46 |
ENSMUST00000231252.2
|
Fst
|
follistatin |
chr15_+_31224555 | 1.45 |
ENSMUST00000186109.2
|
Dap
|
death-associated protein |
chr18_+_36414122 | 1.43 |
ENSMUST00000051301.6
|
Pura
|
purine rich element binding protein A |
chr15_+_25774070 | 1.42 |
ENSMUST00000125667.3
|
Myo10
|
myosin X |
chr10_+_32959472 | 1.40 |
ENSMUST00000095762.5
ENSMUST00000218281.2 ENSMUST00000217779.2 ENSMUST00000219665.2 ENSMUST00000219931.2 |
Trdn
|
triadin |
chr5_+_92535705 | 1.39 |
ENSMUST00000138687.2
ENSMUST00000124509.2 |
Art3
|
ADP-ribosyltransferase 3 |
chr2_-_111100733 | 1.39 |
ENSMUST00000099619.6
|
Olfr1277
|
olfactory receptor 1277 |
chr16_+_44913974 | 1.38 |
ENSMUST00000099498.10
|
Ccdc80
|
coiled-coil domain containing 80 |
chr10_-_44024843 | 1.38 |
ENSMUST00000200401.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr6_-_115569504 | 1.37 |
ENSMUST00000112957.2
|
Mkrn2os
|
makorin, ring finger protein 2, opposite strand |
chr6_-_101176147 | 1.36 |
ENSMUST00000239140.2
|
Pdzrn3
|
PDZ domain containing RING finger 3 |
chr5_+_90708962 | 1.35 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr10_+_68987257 | 1.35 |
ENSMUST00000167286.8
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr11_-_99441687 | 1.34 |
ENSMUST00000092700.5
|
Krtap3-3
|
keratin associated protein 3-3 |
chr7_-_48497771 | 1.33 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr18_+_9707595 | 1.33 |
ENSMUST00000234965.2
|
Colec12
|
collectin sub-family member 12 |
chr16_-_97564910 | 1.31 |
ENSMUST00000019386.10
|
Ripk4
|
receptor-interacting serine-threonine kinase 4 |
chr6_-_52181393 | 1.30 |
ENSMUST00000048794.7
|
Hoxa5
|
homeobox A5 |
chr8_+_23901506 | 1.29 |
ENSMUST00000033952.8
|
Sfrp1
|
secreted frizzled-related protein 1 |
chr11_-_99412162 | 1.29 |
ENSMUST00000107445.8
|
Krt39
|
keratin 39 |
chr2_+_110551927 | 1.29 |
ENSMUST00000111017.9
|
Muc15
|
mucin 15 |
chr9_-_79885063 | 1.29 |
ENSMUST00000093811.11
|
Filip1
|
filamin A interacting protein 1 |
chr17_-_35101069 | 1.28 |
ENSMUST00000025230.15
|
C2
|
complement component 2 (within H-2S) |
chr3_-_88194517 | 1.27 |
ENSMUST00000165196.8
|
Gm38392
|
predicted gene, 38392 |
chr1_-_189902868 | 1.26 |
ENSMUST00000177288.4
ENSMUST00000175916.8 |
Prox1
|
prospero homeobox 1 |
chr5_+_90666791 | 1.25 |
ENSMUST00000113179.9
ENSMUST00000128740.2 |
Afm
|
afamin |
chr15_-_96929086 | 1.24 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chrX_+_156481906 | 1.24 |
ENSMUST00000136141.2
ENSMUST00000190091.7 |
Smpx
|
small muscle protein, X-linked |
chr4_-_104733580 | 1.24 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr19_+_24651362 | 1.24 |
ENSMUST00000057243.6
|
Tmem252
|
transmembrane protein 252 |
chr3_-_129518723 | 1.24 |
ENSMUST00000199615.5
ENSMUST00000197079.5 |
Egf
|
epidermal growth factor |
chr2_+_74528071 | 1.24 |
ENSMUST00000059272.10
|
Hoxd9
|
homeobox D9 |
chrX_+_156482116 | 1.23 |
ENSMUST00000112521.8
|
Smpx
|
small muscle protein, X-linked |
chr6_-_83654789 | 1.23 |
ENSMUST00000037882.8
|
Cd207
|
CD207 antigen |
chr2_+_110551976 | 1.23 |
ENSMUST00000090332.5
|
Muc15
|
mucin 15 |
chr11_-_99412084 | 1.22 |
ENSMUST00000076948.2
|
Krt39
|
keratin 39 |
chr9_-_79884920 | 1.22 |
ENSMUST00000239133.2
|
Filip1
|
filamin A interacting protein 1 |
chr8_-_11329656 | 1.21 |
ENSMUST00000208095.2
|
Col4a1
|
collagen, type IV, alpha 1 |
chr16_+_37400590 | 1.19 |
ENSMUST00000159787.8
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr3_+_63988968 | 1.19 |
ENSMUST00000029406.6
|
Vmn2r1
|
vomeronasal 2, receptor 1 |
chr17_-_43003135 | 1.19 |
ENSMUST00000170723.8
ENSMUST00000164524.2 ENSMUST00000024711.11 ENSMUST00000167993.8 |
Adgrf4
|
adhesion G protein-coupled receptor F4 |
chr1_-_119576347 | 1.18 |
ENSMUST00000027632.14
ENSMUST00000187194.2 |
Epb41l5
|
erythrocyte membrane protein band 4.1 like 5 |
chr16_+_37400500 | 1.18 |
ENSMUST00000160847.2
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr6_-_147165623 | 1.18 |
ENSMUST00000052296.9
ENSMUST00000204197.2 |
Pthlh
|
parathyroid hormone-like peptide |
chr12_-_57592907 | 1.18 |
ENSMUST00000044380.8
|
Foxa1
|
forkhead box A1 |
chr7_+_43418321 | 1.17 |
ENSMUST00000107970.8
|
Klk12
|
kallikrein related-peptidase 12 |
chr6_+_37847721 | 1.17 |
ENSMUST00000031859.14
ENSMUST00000120428.8 |
Trim24
|
tripartite motif-containing 24 |
chr2_+_83554868 | 1.16 |
ENSMUST00000111740.9
|
Itgav
|
integrin alpha V |
chr6_-_128252540 | 1.13 |
ENSMUST00000130454.8
|
Tead4
|
TEA domain family member 4 |
chr1_-_45542442 | 1.12 |
ENSMUST00000086430.5
|
Col5a2
|
collagen, type V, alpha 2 |
chr2_+_110551685 | 1.12 |
ENSMUST00000111016.9
|
Muc15
|
mucin 15 |
chr17_-_29226700 | 1.12 |
ENSMUST00000233441.2
|
Stk38
|
serine/threonine kinase 38 |
chr2_+_132689640 | 1.11 |
ENSMUST00000124836.8
ENSMUST00000154160.2 |
Crls1
|
cardiolipin synthase 1 |
chr14_+_26722319 | 1.10 |
ENSMUST00000035433.10
|
Hesx1
|
homeobox gene expressed in ES cells |
chr17_-_71160477 | 1.10 |
ENSMUST00000118283.8
|
Tgif1
|
TGFB-induced factor homeobox 1 |
chr1_+_88128323 | 1.10 |
ENSMUST00000049289.9
|
Ugt1a2
|
UDP glucuronosyltransferase 1 family, polypeptide A2 |
chr2_-_27365633 | 1.10 |
ENSMUST00000138693.8
ENSMUST00000113941.9 ENSMUST00000077737.13 |
Brd3
|
bromodomain containing 3 |
chr16_+_33504740 | 1.10 |
ENSMUST00000232568.2
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr7_+_43418404 | 1.08 |
ENSMUST00000014063.6
|
Klk12
|
kallikrein related-peptidase 12 |
chr13_+_55547498 | 1.08 |
ENSMUST00000057167.9
|
Slc34a1
|
solute carrier family 34 (sodium phosphate), member 1 |
chr2_-_72817060 | 1.07 |
ENSMUST00000112062.2
|
Gm11084
|
predicted gene 11084 |
chr13_+_23991010 | 1.07 |
ENSMUST00000006786.11
ENSMUST00000099697.3 |
Slc17a2
|
solute carrier family 17 (sodium phosphate), member 2 |
chr2_+_103255165 | 1.06 |
ENSMUST00000126290.2
|
Elf5
|
E74-like factor 5 |
chr8_-_45747883 | 1.05 |
ENSMUST00000026907.6
|
Klkb1
|
kallikrein B, plasma 1 |
chr9_-_18297277 | 1.05 |
ENSMUST00000166825.8
|
Naalad2
|
N-acetylated alpha-linked acidic dipeptidase 2 |
chr15_-_60793115 | 1.05 |
ENSMUST00000096418.5
|
A1bg
|
alpha-1-B glycoprotein |
chr6_-_101354858 | 1.04 |
ENSMUST00000075994.11
|
Pdzrn3
|
PDZ domain containing RING finger 3 |
chr10_+_102376109 | 1.03 |
ENSMUST00000055355.6
|
Rassf9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
chr16_-_35891739 | 1.03 |
ENSMUST00000231351.2
ENSMUST00000004057.9 |
Fam162a
|
family with sequence similarity 162, member A |
chr7_+_107679062 | 1.02 |
ENSMUST00000213601.2
|
Olfr481
|
olfactory receptor 481 |
chr2_+_9887427 | 1.00 |
ENSMUST00000114919.2
|
4930412O13Rik
|
RIKEN cDNA 4930412O13 gene |
chr7_-_12829100 | 0.99 |
ENSMUST00000209822.3
ENSMUST00000235753.2 |
Vmn1r85
|
vomeronasal 1 receptor 85 |
chr19_-_39637489 | 0.99 |
ENSMUST00000067328.7
|
Cyp2c67
|
cytochrome P450, family 2, subfamily c, polypeptide 67 |
chr6_-_30304512 | 0.99 |
ENSMUST00000094543.3
ENSMUST00000102993.10 |
Ube2h
|
ubiquitin-conjugating enzyme E2H |
chr17_-_48145466 | 0.99 |
ENSMUST00000066368.13
|
Mdfi
|
MyoD family inhibitor |
chr5_-_53864874 | 0.99 |
ENSMUST00000031093.5
|
Cckar
|
cholecystokinin A receptor |
chr14_-_118289557 | 0.99 |
ENSMUST00000022725.4
|
Dct
|
dopachrome tautomerase |
chrX_+_99019176 | 0.98 |
ENSMUST00000113781.8
ENSMUST00000113783.8 ENSMUST00000113779.8 ENSMUST00000113776.8 ENSMUST00000113775.8 ENSMUST00000113780.8 ENSMUST00000113778.8 ENSMUST00000113777.8 ENSMUST00000071453.3 |
Eda
|
ectodysplasin-A |
chr16_-_88303859 | 0.98 |
ENSMUST00000069549.3
|
Cldn17
|
claudin 17 |
chr5_-_53864595 | 0.98 |
ENSMUST00000200691.4
|
Cckar
|
cholecystokinin A receptor |
chr11_+_96209093 | 0.97 |
ENSMUST00000049241.9
|
Hoxb4
|
homeobox B4 |
chr12_-_104439589 | 0.96 |
ENSMUST00000021513.6
|
Gsc
|
goosecoid homeobox |
chr10_-_125164399 | 0.95 |
ENSMUST00000063318.10
|
Slc16a7
|
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
chr1_+_107456731 | 0.94 |
ENSMUST00000182198.8
|
Serpinb10
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10 |
chr17_+_71326510 | 0.94 |
ENSMUST00000073211.13
ENSMUST00000024847.14 |
Myom1
|
myomesin 1 |
chr13_-_114595475 | 0.93 |
ENSMUST00000022287.8
ENSMUST00000223640.3 |
Fst
|
follistatin |
chr2_+_87137925 | 0.93 |
ENSMUST00000216396.3
|
Olfr1118
|
olfactory receptor 1118 |
chr1_-_134883645 | 0.92 |
ENSMUST00000045665.13
ENSMUST00000086444.6 ENSMUST00000112163.2 |
Ppp1r12b
|
protein phosphatase 1, regulatory subunit 12B |
chr15_+_31225302 | 0.91 |
ENSMUST00000186425.7
|
Dap
|
death-associated protein |
chr17_+_71326542 | 0.91 |
ENSMUST00000179759.3
|
Myom1
|
myomesin 1 |
chr1_-_171854818 | 0.89 |
ENSMUST00000138714.2
ENSMUST00000027837.13 ENSMUST00000111264.8 |
Vangl2
|
VANGL planar cell polarity 2 |
chr15_+_31224460 | 0.89 |
ENSMUST00000044524.16
|
Dap
|
death-associated protein |
chr1_+_151446893 | 0.89 |
ENSMUST00000134499.8
|
Niban1
|
niban apoptosis regulator 1 |
chr9_+_102595628 | 0.88 |
ENSMUST00000156485.2
ENSMUST00000145937.2 ENSMUST00000134483.2 ENSMUST00000190047.7 |
Amotl2
|
angiomotin-like 2 |
chr15_-_100322089 | 0.88 |
ENSMUST00000154331.2
|
Slc11a2
|
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
chr2_+_87725306 | 0.86 |
ENSMUST00000217436.2
|
Olfr1153
|
olfactory receptor 1153 |
chr15_+_37233280 | 0.86 |
ENSMUST00000161405.8
ENSMUST00000022895.15 ENSMUST00000161532.2 |
Grhl2
|
grainyhead like transcription factor 2 |
chr9_-_66421868 | 0.86 |
ENSMUST00000056890.10
|
Fbxl22
|
F-box and leucine-rich repeat protein 22 |
chr2_+_31204314 | 0.86 |
ENSMUST00000113532.9
|
Hmcn2
|
hemicentin 2 |
chr11_-_99265721 | 0.84 |
ENSMUST00000006963.3
|
Krt28
|
keratin 28 |
chr2_-_86109346 | 0.83 |
ENSMUST00000217294.2
ENSMUST00000217245.2 ENSMUST00000216432.2 |
Olfr1051
|
olfactory receptor 1051 |
chr3_-_24837772 | 0.82 |
ENSMUST00000203414.2
|
Naaladl2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
chr17_-_29226886 | 0.82 |
ENSMUST00000232723.2
|
Stk38
|
serine/threonine kinase 38 |
chr3_+_159545309 | 0.79 |
ENSMUST00000068952.10
ENSMUST00000198878.2 |
Wls
|
wntless WNT ligand secretion mediator |
chrM_+_7006 | 0.79 |
ENSMUST00000082405.1
|
mt-Co2
|
mitochondrially encoded cytochrome c oxidase II |
chr3_+_138058139 | 0.78 |
ENSMUST00000090166.5
|
Adh6b
|
alcohol dehydrogenase 6B (class V) |
chr9_+_20148415 | 0.76 |
ENSMUST00000086474.6
|
Olfr872
|
olfactory receptor 872 |
chr15_-_100321973 | 0.76 |
ENSMUST00000154676.2
|
Slc11a2
|
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
chr6_-_131662707 | 0.76 |
ENSMUST00000072404.3
|
Tas2r104
|
taste receptor, type 2, member 104 |
chr1_-_134883577 | 0.75 |
ENSMUST00000168381.8
|
Ppp1r12b
|
protein phosphatase 1, regulatory subunit 12B |
chrX_-_99638466 | 0.75 |
ENSMUST00000053373.2
|
P2ry4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
chrX_+_82898974 | 0.74 |
ENSMUST00000239269.2
|
Dmd
|
dystrophin, muscular dystrophy |
chr7_-_103094646 | 0.73 |
ENSMUST00000215417.2
|
Olfr605
|
olfactory receptor 605 |
chr12_+_111780604 | 0.73 |
ENSMUST00000021714.9
ENSMUST00000223211.2 ENSMUST00000222843.2 ENSMUST00000221375.2 |
Zfyve21
|
zinc finger, FYVE domain containing 21 |
chr6_-_84565613 | 0.73 |
ENSMUST00000204146.3
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1 |
chr12_+_38830283 | 0.72 |
ENSMUST00000162563.8
ENSMUST00000161164.8 ENSMUST00000160996.8 |
Etv1
|
ets variant 1 |
chr12_-_101784727 | 0.70 |
ENSMUST00000222587.2
|
Fbln5
|
fibulin 5 |
chr4_+_8690398 | 0.70 |
ENSMUST00000127476.8
|
Chd7
|
chromodomain helicase DNA binding protein 7 |
chr3_+_121838076 | 0.70 |
ENSMUST00000013995.13
|
Abca4
|
ATP-binding cassette, sub-family A (ABC1), member 4 |
chr4_+_19280850 | 0.70 |
ENSMUST00000102999.2
|
Cngb3
|
cyclic nucleotide gated channel beta 3 |
chr9_+_121780054 | 0.69 |
ENSMUST00000043011.9
ENSMUST00000214536.3 ENSMUST00000215990.3 |
Gask1a
|
golgi associated kinase 1A |
chrX_+_138464065 | 0.69 |
ENSMUST00000113027.8
|
Rnf128
|
ring finger protein 128 |
chr8_-_26609153 | 0.69 |
ENSMUST00000037182.14
|
Hook3
|
hook microtubule tethering protein 3 |
chr13_-_56399976 | 0.69 |
ENSMUST00000058475.6
|
Neurog1
|
neurogenin 1 |
chr16_+_34815177 | 0.68 |
ENSMUST00000231589.2
|
Mylk
|
myosin, light polypeptide kinase |
chr11_+_23256883 | 0.68 |
ENSMUST00000180046.8
|
Usp34
|
ubiquitin specific peptidase 34 |
chr8_-_41494890 | 0.68 |
ENSMUST00000051379.14
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr1_+_88093726 | 0.67 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr18_-_44795317 | 0.67 |
ENSMUST00000164666.6
|
Mcc
|
mutated in colorectal cancers |
chr13_-_103042294 | 0.67 |
ENSMUST00000167462.8
|
Mast4
|
microtubule associated serine/threonine kinase family member 4 |
chr16_+_43574389 | 0.67 |
ENSMUST00000229953.2
|
Drd3
|
dopamine receptor D3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
1.1 | 10.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.9 | 2.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.9 | 8.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 2.3 | GO:0001966 | thigmotaxis(GO:0001966) |
0.6 | 1.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 2.4 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.5 | 1.6 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.5 | 2.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 1.3 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
0.4 | 1.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.4 | 1.3 | GO:2000041 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.4 | 1.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 23.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 1.2 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.4 | 1.2 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 1.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 2.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 3.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 2.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) positive regulation of somatostatin secretion(GO:0090274) |
0.3 | 2.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 1.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 2.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 0.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.1 | GO:0003017 | lymph circulation(GO:0003017) |
0.3 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 2.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.8 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.2 | 1.5 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.2 | 0.7 | GO:0021629 | olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
0.2 | 1.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 1.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.7 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.2 | 2.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.2 | 1.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.7 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.2 | 0.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.6 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.2 | 0.6 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.2 | 0.9 | GO:0072199 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 1.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.7 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.2 | 3.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 4.8 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 3.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 1.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.6 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.8 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 1.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.6 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic metaphase plate congression(GO:0051311) |
0.1 | 0.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 2.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.3 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.1 | 1.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.1 | 0.7 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.1 | 0.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.1 | 0.4 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.1 | 0.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 1.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 1.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 1.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 1.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 5.5 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 1.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 2.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 5.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 4.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.2 | GO:1903487 | regulation of lactation(GO:1903487) |
0.1 | 2.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.5 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.1 | 1.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.7 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.4 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.2 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.1 | 0.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 1.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 1.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 5.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.0 | 1.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 1.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 1.5 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.2 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.5 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 1.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 2.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 2.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 1.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 4.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.6 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.3 | GO:0090336 | regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 4.1 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 1.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 2.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 5.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 3.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.5 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 13.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.7 | GO:0034686 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
1.1 | 5.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 1.7 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.5 | 1.6 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.4 | 1.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 2.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 1.5 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 6.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) late recombination nodule(GO:0005715) |
0.2 | 8.2 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.8 | GO:0035841 | new growing cell tip(GO:0035841) |
0.2 | 3.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 3.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 6.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 9.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 2.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 2.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 7.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 4.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 2.0 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.7 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 1.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.0 | 1.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 6.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 32.7 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.9 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 3.3 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 1.1 | GO:0043195 | terminal bouton(GO:0043195) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.1 | 23.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 1.6 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.5 | 3.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 4.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 2.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.5 | 8.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 1.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 1.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.4 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 8.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 7.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 5.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.7 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.2 | 1.5 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 0.7 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.2 | 0.7 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.6 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
0.2 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 4.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.7 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.2 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 1.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 2.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 4.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 9.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 5.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 3.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.1 | 1.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 3.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 11.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 2.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 1.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 3.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 1.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 7.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 1.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 1.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 8.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 3.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.1 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 11.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 7.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 4.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 3.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 4.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 3.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 2.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 5.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 2.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |